Matches in Nanopublications for { ?s ?p "[Reciprocal IGH/14q32 translocations are detectable in 55-70% of patients with plasma cell myeloma; e.g., the adverse t(4;14)(p16;q32) fusing the IGH and FGFR3 genes (immunoglobulin heavy chain/fibroblast growth factor receptor 3).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Reciprocal IGH/14q32 translocations are detectable in 55-70% of patients with plasma cell myeloma; e.g., the adverse t(4;14)(p16;q32) fusing the IGH and FGFR3 genes (immunoglobulin heavy chain/fibroblast growth factor receptor 3).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP825032.RAGfZphINDDF36EKOfTshwOlbrBijDyW50afY5yD6UqSE130_assertion description "[Reciprocal IGH/14q32 translocations are detectable in 55-70% of patients with plasma cell myeloma; e.g., the adverse t(4;14)(p16;q32) fusing the IGH and FGFR3 genes (immunoglobulin heavy chain/fibroblast growth factor receptor 3).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825032.RAGfZphINDDF36EKOfTshwOlbrBijDyW50afY5yD6UqSE130_provenance.
- NP825033.RA6QY8CEKbm7nfzE_ny4ViOPLrAepCwXufiU55ohhC8vw130_assertion description "[Reciprocal IGH/14q32 translocations are detectable in 55-70% of patients with plasma cell myeloma; e.g., the adverse t(4;14)(p16;q32) fusing the IGH and FGFR3 genes (immunoglobulin heavy chain/fibroblast growth factor receptor 3).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825033.RA6QY8CEKbm7nfzE_ny4ViOPLrAepCwXufiU55ohhC8vw130_provenance.